XML 22 R11.htm IDEA: XBRL DOCUMENT
v3.22.1

Goodwill and Other Intangible Assets | 3 Months Ended
--- | ---
Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND OTHER INTANGIBLE ASSETS | NOTE C – GOODWILL AND OTHER INTANGIBLE ASSETS The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:
| As of March 31, 2022 |  | As of December 31, 2021
(in millions) | Gross Carrying Amount |  | Accumulated Amortization/ Write-offs |  | Gross Carrying Amount |  | Accumulated Amortization/ Write-offs
Technology-related | $ | 12,559 |  |  | $ | (6,918) |  |  | $ | 11,957 |  |  | $ | (6,754) |
Patents | 489 |  |  | (393) |  |  | 494 |  |  | (398) |
Other intangible assets | 1,946 |  |  | (1,347) |  |  | 1,900 |  |  | (1,325) |
Amortizable intangible assets | $ | 14,994 |  |  | $ | (8,659) |  |  | $ | 14,351 |  |  | $ | (8,476) |
Goodwill | $ | 22,849 |  |  | $ | (9,900) |  |  | $ | 21,888 |  |  | $ | (9,900) |
IPR&D | $ | 126 |  |  |  |  | $ | 126 |  |  |
Technology-related | 120 |  |  |  |  | 120 |  |  |
Indefinite-lived intangible assets | $ | 246 |  |  |  |  | $ | 246 |  |  |
The increase in our balance of goodwill and intangible assets is primarily related to our acquisition of Baylis Medical completed in the first quarter of 2022. The following represents our goodwill balance by global reportable segment:
(in millions) | MedSurg |  | Cardiovascular |  |  |  | Total
As of December 31, 2021 | $ | 4,246 |  |  | $ | 7,741 |  |  |  |  | $ | 11,988 |
Impact of foreign currency fluctuations and other changes in carrying value | (2) |  |  | (24) |  |  |  |  | (27) |
Goodwill acquired | — |  |  | 988 |  |  |  |  | 988 |
As of March 31, 2022 | $ | 4,244 |  |  | $ | 8,705 |  |  |  |  | $ | 12,949 |
In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into two reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. We have revised prior periods to conform to the current year presentation. We did not record any goodwill or intangible asset impairment charges in the first quarter of 2022 or 2021. Refer to Note A – Basis of Presentation to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration